Archives
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
DiscoveryProbe Metabolism-related Compound Library
2026-09-30
Translate metabolomic observations into tractable enzyme, cell, and pathway screens with a curated 493-compound collection. This workflow shows how to connect lipid remodeling and stress-response findings from burn research with reproducible metabolic perturbation assays, while controlling for potency, cytotoxicity, and DMSO effects.
-
Triacetin: From Digestion to Research Design
2026-09-29
Triacetin, or glyceryl triacetate, is more than a synthetic triglyceride: its rapid conversion to acetate and glycerol changes how metabolic, oncology, and ocular assays should be designed. This evidence-led guide connects biochemical fate with exposure controls, mechanistic interpretation, and reproducible workflow decisions.
-
TRIM21–ERK1/2 Signaling in Pituitary Adenomas
2026-09-29
The reference study identifies TRIM21 as a context-dependent regulator of ERK1/2 signaling, pituitary adenoma proliferation, and resistance to dopamine agonists. Its combination of CRISPR screening, proteomics, ubiquitination analysis, and drug screening positions TRIM21 suppression as a testable strategy while highlighting the importance of ERK1/2 feedback.
-
Temafloxacin Workflows for Antibacterial Research
2026-09-28
Temafloxacin supports concentration-controlled MIC testing, respiratory-pathogen profiling, and intracellular mycobacterial workflows in one research compound. This guide connects published susceptibility data with practical preparation, assay design, and troubleshooting strategies for reproducible antibacterial experiments.
-
Panobinostat (LBH589): Assay Design and Reliability
2026-09-28
Practical guidance for using Panobinostat (LBH589), SKU A8178, in viability, proliferation, and apoptosis experiments. Learn how to interpret cell-line potency benchmarks, handle the DMSO-soluble compound, and design cautious combination studies grounded in published evidence.
-
hCG Silences CXCL10 Through H3K27 Methylation
2026-09-27
The study links trophoblast-derived human chorionic gonadotropin (hCG) to reduced CXCL10 expression in human decidual stromal cells through EZH2-mediated H3K27 trimethylation at the CXCL10 promoter. By connecting a hormonal signal to chromatin state and CD8-cell recruitment, it identifies an epigenetic mechanism that may help shape immune access at the maternal–fetal interface.
-
GSK J4 HCl for JMJD3 and CXCL10 Assays
2026-09-26
Use GSK J4 HCl to test whether JMJD3-dependent H3K27 demethylation contributes to chemokine regulation in decidual-cell models—not as a substitute for testing the hCG–EZH2 pathway directly. This guide connects the reference study to a practical dose-response, chromatin, and chemotaxis workflow, with controls to separate target-level effects from cell stress.
-
Belinostat (PXD101): Workflows for HDAC Research
2026-09-25
Belinostat (PXD101) provides a practical tool for testing histone deacetylase inhibition, histone acetylation, and growth responses in cancer cell models. This guide separates established bladder and prostate benchmarks from a carefully controlled, hypothesis-testing workflow for studying HDAC inhibition alongside spliceosome and PARP-inhibitor biology in hepatocellular carcinoma.
-
Apicidin Disrupts Oocyte Maturation and Epigenetic Control
2026-09-25
A 2026 in vitro oocyte study reports that Apicidin delays meiotic maturation while disrupting spindle and chromosome organization, reducing actin filament density, and changing histone and tubulin acetylation. The findings connect a food- and feed-associated mycotoxin with measurable defects in germ-cell quality, while leaving dose relevance and the causal role of HDAC changes open for further study.
-
Berberrubine and Metabolic Recovery in Fatty Liver Disease
2026-09-24
A 2022 study tested berberrubine, a major berberine metabolite, in high-fat-diet mice and oleic-acid-treated HepG2 cells, reporting improvements in hepatic steatosis and insulin resistance alongside changes in metabolic proteins and gut microbiota. The findings support berberrubine as a candidate for further mechanistic and translational study, while leaving human efficacy and microbiome causality unresolved.
-
NADH Redox Control in Fungal Metabolism
2026-09-24
NADH is more than an electron carrier: its balance with NAD⁺ can shape how filamentous fungi adapt to oxygen limitation and produce metabolites. This article translates a fungal redox-homeostasis review into practical assay decisions while clarifying what its findings do—and do not—imply for other NADH research.
-
SmD2 Acetylation Links HCC Splicing to PARP Sensitivity
2026-09-23
This study identifies an acetylation-controlled role for the spliceosome protein SmD2 in hepatocellular carcinoma (HCC): HDAC2-mediated deacetylation stabilizes SmD2, which influences BRCA1/FANC cassette-exon processing and DNA-damage repair. Disrupting this pathway, including with Romidepsin alongside the PARP inhibitor olaparib, sensitized HCC models to PARP inhibition and suggests a preclinical strategy for tumors without established BRCA deficiency.
-
SmD2 Acetylation Links Splicing to PARP Sensitivity
2026-09-23
This study identifies SmD2 acetylation as a regulatory link between core spliceosome function, BRCA1/FANC cassette-exon processing, and DNA-damage repair in hepatocellular carcinoma. Its findings support combining HDAC2-directed intervention with PARP inhibition to increase treatment sensitivity in HCC models.
-
Cholesterol: From Membrane Variable to Assay Insight
2026-09-22
Cholesterol is the principal sterol for interpreting membrane behavior, lipid metabolism research, and delivery-associated cell responses. This article presents a causal assay framework that distinguishes direct cholesterol effects from lipid nanoparticle and p21 mRNA biology.
-
AMC-Hem Illuminates Real-Time HO-1 Regulation
2026-09-22
The reference study introduces AMC-Hem, a red-shifted aminocoumarin–heme fluorescent probe designed to report heme oxygenase-1 activity rather than simply protein abundance. In live human macrophages and serum, the probe revealed compartmentalized HO-1 activity, non-transcriptional regulation by small molecules, and a practical route toward dynamic biochemical measurements.